BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Medicinal products containing pelargonium: risk of liver damage

Active substance: pelargonium

After having conducted a hearing within a graduated plan procedure ("Stufenplanverfahren"), the BfArM has now issued a notice regarding the risk of liver damage due to medicinal products containing pelargonium root.

To the graduated plan procedure (available in German only)